The Granzyme B ELISPOT assay: An alternative to the 51Cr-release assay for monitoring cell-mediated cytotoxicity

Journal of Translational Medicine

Volumn 1, Issue , 2003, Pages

  Shafer Weaver, Kimberly ^a   Sayers, Thomas ^b   Strobl, Susan ^a   Derby, Eric ^a   Ulderich, Tracy ^a   Baseler, Michael ^a   Malyguine, Anatoli ^a  

^a SAIC FREDERICK INC   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER VACCINE; CD8 ANTIGEN; CHROMIUM 51; GAMMA INTERFERON; GRANZYME B; PEPTIDE DERIVATIVE;

ANTIGEN SPECIFICITY; ARTICLE; CELL COUNT; CELL DEATH; CELL GRANULE; CELL INTERACTION; CELL MEDIATED CYTOTOXICITY; CELL SPECIFICITY; CHROMIUM 51 RELEASE; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOKINE RELEASE; CYTOTOXIC T LYMPHOCYTE; EFFECTOR CELL; ENZYME LINKED IMMUNOSPOT ASSAY; ENZYME RELEASE; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IN VITRO STUDY; INCUBATION TIME; INTERMETHOD COMPARISON; LYMPHOCYTE CULTURE; LYMPHOCYTE FUNCTION; MEDICAL ASSESSMENT; NATURAL KILLER CELL; PATIENT MONITORING; SENSITIVITY AND SPECIFICITY; T LYMPHOCYTE ACTIVATION; TARGET CELL; TIME; TITRIMETRY;

EID: 3342925367     PISSN: 14795876     EISSN: None     Source Type: Journal    
DOI: 10.1186/1479-5876-1-14     Document Type: Article

References (35)

1. Keilholz U, Weber J, Finke JH, Gabrilovich DI, Kast WM, Disis ML, Kirkwood JM, Scheibenbogen C, Schlom J, Maino VC, Lyerly HK, Lee PP, Storkus W, Marincola F, Worobec A, Atkins MB: Immunologic monitoring of cancer vaccine therapy: results of a workshop sponsored by the Society for Biological Therapy. J Immunother 2002, 25:97-138.
2. Regner M, Lobigs M, Blanden RV, Mullbacher A: Effector cytolotic function but not IFN-gamma production in cytotoxic T cells triggered by virus-infected target cells in vitro. Scand J Immunol 2001, 54:366-374.
3. Lim DG, Bourcier K Bieganowska, Freeman GJ, Hafler DA: Examination of CD8+ T cell function in humans using MHC class I tetramers: similar cytotoxicity but variable proliferation and cytokine production among different clonal CD8+ T cells specific to a single viral epitope. J Immunol 2000, 165:6214-6220.
4. Slifka MK, Rodriguez F, Whitton JL: Rapid on/off cycling of cytokine production by virus-specific CD8+ T cells. Nature 1999, 401:76-79.
5. Bachmann MF, Barner M, Viola A, Kopf M: Distinct kinetics of cytokine production and cytolysis in effector and memory T cells after viral infection. Eur J Immunol 1999, 29:291-299.
6. Masopust D, Vezys V, AL AL Marzo, L L Lefrancois: Preferential localization of effector memory cells in nonlymphoid tissue. Science 2001, 291:2413-2417.
7. Trinchieri G, Perussia B: Human natural killer cells: biologic and pathologic aspects. Lab Invest 1984, 50:489-513.
8. Smyth MJ, Trapani JA: Granzymes: exogenous proteinases that induce target cell apoptosis. Immunol Today 1995, 16:202-206.
9. Finn OJ, Lotze MT: A decade in the life of tumor immunology. Clin Cancer Res 2001, 7:759s-760s.
10. Kagi D, Hengartner H: Different roles for cytotoxic T cells in the control of infections with cytopathic versus noncytopathic viruses. Curr Opin Immunol 1996, 8:472-477.
11. Clark WR, Walsh CM, Glass AA, Huang MT, R R Ahmed, Matloubian M: Cell-mediated cytotoxicity in perforin-less mice. Int Rev Immunol 1995, 13:1-14.
12. Podack ER: Execution and suicide: cytotoxic lymphocytes enforce Draconian laws through separate molecular pathways. Curr Opin Immunol 1995, 7:11-16.
13. Berke G: The CTL's kiss of death. Cell 1995, 81:9-12.
14. Liu CC, PM PM Persechini, Young JD: Perforin and lymphocyte-mediated cytolysis. Immunol Rev 1995, 146:145-175.
15. Jenne DE, Tschopp J: Granzymes, a family of serine proteases released from granules of cytolytic T lymphocytes upon T cell receptor stimulation. Immunol Rev 1988, 103:53-71.
16. Tschopp J, Nabholz M: Perforin-mediated target cell lysis by cytolytic T lymphocytes. Annu Rev Immunol. 1990, 8:279-302.
17. Rininsland FH, Helms T, Asaad RJ, Boehm BO, Tary-Lehmann M: Granzyme B ELISPOT assay for ex vivo measurements of T cell immunity. J Immunol Methods 2000, 240:143-155.
18. Derby EG, Reddy V, Nelson EL, Kopp WC, Baseler MW, Dawson JR, Malyguine AM: Correlation of human CD56+ cell cytotoxicity and IFN-gamma production. Cytokine 2001, 13:85-90.
19. Pham CTN, Ley TJ: The role of granzyme B cluster proteases in cell-mediated cytotoxicity. Semin Immunol 1997, 9:127-133.
20. Burkhardt JK, Hester S, Lapham CK, Argon Y: The lytic granules of natural killer cells are dual-function organelles combining secretory and pre-lysosomal compartments. J Cell Biol 1990, 111:2327-2340.
21. Bleackley RC, Lobe CG, Duggan B, Ehrman N, Fregeau C, M M Meier, Letellier M, Havele C, Shaw J, Paetkau V: The isolation and characterization of a family of serine protease genes expressed in activated cytotoxic T lymphocytes. Immunol Rev 1988, 103:5-19.
22. Doherty PC, Christensen JP: Accessing complexity: the dynamics of virus-specific T cell responses. Annu Rev Immunol. 2000, 18:561-592.
23. Russell JH, Ley TJ: Lymphocyte-mediated cytotoxicity. Annu Rev Immunol. 2002, 20:323-370.
24. Griffiths GM: Protein sorting and secretion during CTL killing. Semin Immunol 1997, 9:109-115.
25. Henkart PA: CTL effector functions. Semin Immunol 1997, 9:85-86.
26. Snyder JE, Bowers WJ, Livingstone AM, Lee FE, Federoff HJ, Mosmann TR: Measuring the frequency of mouse and human cytotoxic T cells by the Lysispot assay: independent regulation of cytokine secretion and short-term killing. Nat Med 2003, 9:231-236.
27. Mahajan SD, Aalinkeel R, Schwartz SA, Chawda RP, Nair MPN: Effector cell mediated cytotoxicity measured by intracellular granzyme B release in HIV infected subjects. Biol. Proced. Online 2003, 5:182-188.
28. Derby E, Reddy V, Baseler M, Malyguine A: Flow cytometric assay for the simultaneous analysis of cell-mediated cytotoxicity and effector cell phenotype. Biotechniques 2001, 31:664-665.
29. Smyth MJ, Street SEA, Trapani JA: Cutting Edge: Granzymes A and B are not essential for perforin-mediated tumor rejection. J Immunol 2003, 171:515-518.
30. Smyth MJ, Thia KY, Street SE, MacGregor D, Godfrey DI, Trapani JA: Perforin-mediated cytotoxicity is critical for surveillance of spontaneous lymphoma. J Exp Med 2000, 192:755-760.
31. Davis JE, Smyth MJ, Trapani JA: Granzyme A and B-deficient killer lymphocytes are defective in eliciting DNA fragmentation but retain potent in vivo anti-tumor capacity. Eur J Immunol 2001, 31:39-47.
32. Sayers TJ, Wiltrout TA, Sowder R, Munger WL, Smyth MJ, Henderson LE: Purification of a factor from the granules of a rat natural killer cell line (RNK) that reduces tumor cell growth and changes tumor morphology. Molecular identity with a granule serine protease (RNKP-1). J Immunol 1992, 148:292-300.
33. Motyka B, Korbutt G, Pinkoski MJ, Heibein JA, Caputo A, Hobman M, Barry M, Shostak I, Sawchuk T, Holmes CF, Gauldie J, RC. RC Bleackley: Mannose 6-phosphate/insulin-like growth factor II receptor is a death receptor for granzyme B during cytotoxic T cell-induced apoptosis. Cell 2000, 103:491-500.
34. Smyth MJ, Kelly JM, Sutton VR, Davis JE, Browne KA, Sayers TJ, Trapani JA: Unlocking the secrets of cytotoxic granule proteins. J Leukoc Biol 2001, 70:18-29.
35. Medema JP, Jong J de, Peltenburg LT, Verdegaal EM, Gorter A, Bres SA, Franken KL, JP M Hahne, Albar JP, Melief CJ, Offringa R: Blockade of the granzyme B/perforin pathway through overexpression of the serine protease inhibitor PI-9/SPI-6 constitutes a mechanism for immune escape by tumors. Proc Natl Acad Sci U S A 2001, 98:11515-11520.